Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
Alcohol worsens fatty liver, significantly increasing mortality in high-risk patients, even with moderate intake
Recent study highlights aldafermin’s ability to reverse liver cirrhosis due to fatty liver by reducing fibrosis in patients. A significant breakthrough in treatment prospects.
We analyse the latest results of the study conducted with Resmetirom for the treatment of fatty liver disease.
Statins are effective in treating cardiovascular and liver diseases, reducing risks and improving hepatic health.
A recent study in The Lancet reveals that prevalence has tripled since 2000, with a notable increase in women and over 65 years
The study reveals that aspirin, administered for 6 months, reduces hepatic fat, improves inflammation and fibrosis in patients with fatty liver.
We analyzed the association between fatty liver disease and heavy metal exposure.
Recent studies reveal a significant connection between poor sleep duration and the risk of developing fatty liver disease.
23 de August de 2018
27 de July de 2020
20 de May de 2022
Up to 30% of patients with cryptogenic hepatitis can be caused by the seronegative hidden infection by hepatitis C virus (HIC).
It is a liver disease of an inflammatory nature and can develop chronically.
It is a viral infection of the liver that causes inflammation of the liver and the death of hepatocytes.
Hepatitis E is an acute inflammatory disease of the liver that can lead to fulminant hepatitis.
It is a progressive chronic inflammatory disease of the liver that can lead to liver cirrhosis.
It is a chronic progressive liver disease that mainly affects women (90% of cases) from the fourth decade of life.